BISHOP SIMON IN THE MEDIA
Bishop Simon is a respected UK health & safety, biosafety management company. The founder, Dr Shurene Bishop is an experienced biosafety, health and safety consultant listed on the Occupational Safety and Health Consultant Register. The company, Bishop Simon was founded in 2018 and offers a range of services. Based in London, Shurene works all over the UK. If your company needs risk assessment, management guidance Contact Bishop Simon today.
Would you like to know more about the services on offer?
Audits vs Inspections – Is your Organisation Compliant?
What you need to know... Many times, we hear people using the word audits to describe the health and safety checks they have done, when they have really carried out inspections. It is important to understand their differences, and conduct both. An audit cannot substitute an inspection, and vice versa. Both are vital for management of health and safety and biosafety risks, to protect workers, the community, and the environment...
Read MoreBiosafety Compliance – Approved List of Biological Agents
Biosafety Compliance - Regulations There is so much to learn about biosafety compliance but health and safety regulations require that employees are provided with information and training to carry out their work safely. You can learn more about biosafety and at your convenience by taking our IOSH approved biosafety course. After completion of this course you will receive a certificate from IOSH. Compliance and Enforcement If your organisation will...
Read MoreBoost Your GMM Therapy Drug Clinical Trial Recruitment
Since 2015, the pharmaceutical industry has seen a significant increase in the design and trial of gene therapy drugs that are based on genetically modified microorganisms (GMM). This is largely due to the clever application of genetic engineering which has created new biological tools such as Crispr/Casp 9 and replication incompetent target specific viral vectors. These tools are special as their application allows targeted delivery of gene therapy, therefore reducing...
Read MoreThree Steps to Boost your GMM Drug Clinical Trial Recruitment – Condensed – LBIC News 2022
The pharmaceutical industry has seen a significant increase recently in the design and trial of drugs based on genetically modified microorganisms (GMM). This trend is likely to continue as new genetic engineering technologies become available, meaning more clinical trials and demand for patient recruitment.
Read MoreBishop Simon LBIC (2021)
Biosafety: A Brief Introduction to Compliance - By Dr Shurene Bishop Simon, Director of Bishop Simon (A health, safety and biosafety consultancy)
Read More